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CASE REPORT
A case of systemic lupus erythematosus 
presenting as bilateral avascular necrosis 
of femur
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Abstract 
Background: Avascular necrosis occur as a result of diverse etiology. Chronic inflammatory conditions such as 
systemic lupus erythematosus considered as a recognize cause. Many cases were reported in systemic lupus erythe-
matosus after treating with corticosteroids. We report a case of a corticosteroid naïve patient presented as bilateral 
avascular necrosis of femoral head and later progressed to a case of systemic lupus erythematosus.
Case presentation: A 26 year old lady presented with right sided hip pain and diagnosed as avascular necrosis of 
the femoral head. After 6 months she presented a similar pain in left hip, which revealed avascular necrosis of left 
femoral head as well. A probable cause for her clinical presentation could not be found after extensive clinical and 
laboratory evaluation. Patient reported high erythrocyte sedimentation rate persistently, and over the next few years 
progressed as a case of systemic lupus erythematosus.
Conclusion: Above case illustrated avascular necrosis could be an early musculoskeletal manifestation of systemic 
lupus erythematosus even in the absence of corticosteroid administration.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Avascular necrosis (AVN) also known as osteonecrosis 
occur as a result of diverse etiology. Chronic inflamma-
tory disorders, high-dose corticosteroids, excess alcohol 
intake, smoking, trauma, sickle cell disease, infections 
such as human immunodeficiency virus (HIV), tubercu-
losis, meningococcal infections are some of the common 
causes AVN of bone [1, 2]. Systemic lupus erythemato-
sus (SLE) is an autoimmune, chronic inflammatory mul-
tisystem connective tissue disease and AVN of bone is a 
well recognized complication of SLE [3]. Musculoskeletal 
manifestation of SLE is diverse including arthralgia, sino-
vitis, myositis, myopathy and AVN of bone which occur 
in variable frequencies at various stages of the disease. 
SLE can evolve and progress over years with various mul-
tisystem clinical manifestations before definitive diagno-
sis made and a definitive diagnosis can be delayed up to 
5  years [a]. Many cases were reported of multiple AVN 
of bones in patient with SLE, who has been treated with 
corticosteroids. AVN in single or multiple joints as an 
early manifestation of SLE in a patient who has not pre-
viously treated with corticosteroids is not a known asso-
ciation [3–5]. We report a case of a steroid naïve patient 
presented as bilateral AVN of femoral head and later pro-
gressed to SLE.
Case report
A 26 year old female has been referred to our clinic with 
right sided hip pain of sub acute onset. Her pain wors-
ened with movement and weight bearing. On clinical 
examination, she had restricted range of movement with 
pain and mild joint tenderness. On plain x-ray she found 
to have AVN of right femoral head suggested by classical 
crescent sign with preserved articular margins on plain 
film and underwent extensive evaluation for a cause. 
Apart from malaise, fatiguability and moderately elevated 
erythrocyte sedimentation rate (ESR) of 65 mm in 1st h 
no other symptom or laboratory feature could be found. 
Her hemoglobin level was 10.6 g/dL and white cell count, 
platelet count, C-reactive protein was normal. After 
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6 months she presented with a similar pain in left hip and 
subsequent work up revealed AVN of left femoral head as 
well on plain x-ray and findings were similar to the previ-
ous right sided hip joint. Other than above presentation 
she had no other complains at that point. Her past medi-
cal history was not significant, she gave birth to a healthy 
term baby 7 months prior to above presentations and her 
obstetric history was uneventful. She did not consume 
alcohol and was a non-smoker. She was not on any form 
of corticosteroid or other medications prior to the event 
except nutritional supplements during antenatal period 
and she has not taken any indigenous medicines. There 
was no family history of connective tissue or other auto-
immune condition of note. At the time she of the second 
event of hip pain she underwent a comprehensive work 
up with involvement of a multidisciplinary specialists. 
In view of persistently high ESR and multiple AVN of 
bones, she underwent a work up for chronic infections 
such as tuberculosis, and for autoimmune connective 
tissue diseases with serological studies including antinu-
clear antibody (ANA), Anti Smith antibody (Sm), serum 
complements C3 and C4, Anti Ro and Anti La antibodies. 
She was also screen for Human Immunodeficiency Virus 
(HIV) infection, Hepatitis B and C infections. Hemato-
logical evaluation for sickle cell disease, thrombophilic 
conditions including anti-cardiolipin antibodies IgG and 
lupus anticoagulant test, beta-2 glycoprotein 1 both IgM 
and IgG. All of the above tests were negative. A probable 
cause could not be ascertained despite above extensive 
workup. She has been continuously followed up with a 
future plan of hip joint replacement. During the subse-
quent period patient revealed that she felt mild fatigu-
ability and hair loss continuously, which she considered 
not significant and did not report to the doctor hence 
further workup was not done for next 4 years. She did not 
take any medications except simple paracetamol for hip 
pains. After about 4  years of above events she reported 
significant hair loss, which was unusually high accord-
ing to her. On further assessment she found to have iso-
lated thrombocytopenia of less than 100,000/mm3 on 
repeated blood counts and also continuously high ESR, 
at times exceeding 100 mm/1st h. Patient was re-evalu-
ated considering above developments. She had positive 
ANA with titre above 1:160 and a positive anti double 
stranded DNA (dsDNA) antibody with titre of 233  IU/
mL. Both these tests were negative 3 years back. She did 
not report abnormality in urinalysis or neuropsychiatric 
manifestations of SLE. In light of above clinical manifes-
tations and serological studies, definite diagnosis of SLE 
was made according to SLICC 2012 classification criteria. 
Her coagulation screening was repeated and was negative 
although beta-2 glycoprotein 1 was not repeated. Her ini-
tial presentation of bilateral AVN of femoral head 4 years 
back was ascertained as related to evolving autoimmune 
disease, since no other etiology was evidenced. Patient 
was prescribed hydroxy-chloroquine and simple analge-
sics in her subsequent management and total hip joints 
replacement surgery was planned.
Discussion
AVN or osteonecrosis is caused by loss of blood supply to 
a part of bone leading to bone necrosis and collapse [1]. 
Diverse etiologies have been described for AVN. Chronic 
inflammatory conditions such as SLE considered as a well 
known cause [2]. In a patient of SLE, several factors can 
lead to bone ischemia and AVN include Raynaud’s phe-
nomenon, vasculitis, fat emboli, corticosteroids, and the 
antiphospholipid syndrome [3, 6]. Although the above 
patient had evidence of a chronic inflammatory disor-
der such as malaise and high ESR at the outset, she didn’t 
have sufficient criteria fulfilling the diagnosis of SLE or 
any other autoimmune disorder and she was not on any 
form of corticosteroid treatment. AVN is known to asso-
ciated with pregnancy although in this patients onset was 
well beyond the post partum period of 7 and 13 months. 
Many reviews observed that AVN often develops shortly 
after the onset of high-dose corticosteroid therapy [7]. 
Numerous case reports and case series were reported 
AVN in already diagnosed SLE patients and after ini-
tiation of corticosteroid therapy, some of them reported 
AVN in multiple sites [6].
Gontero et  al. [3] conducted a study among 158 SLE 
patients and 15 patients (9.5  %) had AVN, however all 
were on corticosteroids for variable durations and dos-
ages, but no association was found with the dosage or 
disease activity of SLE with the development of AVN. 
Another study conducted to evaluate the prevalence of 
AVN in patient with SLE and antiphospholipid syndrome 
(APLS) and who were not on corticosteroids, using mag-
netic resonant imaging (MRI) [5]. This study evaluated 
asymptomatic patients including 19 SLE patients, 30 pri-
mary APLS patients and 30 healthy subjects, all of them 
were not on corticosteroids. AVN was not reported in 
any of the above SLE patient or healthy subjects although 
six APLS patients revealed AVN on MRI studies [5]. 
However our patient was repeatedly negative for APLS 
screening. In our rigorous literature search we could not 
find a reporting of AVN either single or multiple sites as 
early manifestation of steroid naïve SLE patient. Above 
case illustrates a patient with a features chronic inflam-
matory disorder developing bilateral AVN in femoral 
heads and later progressed to SLE over next few years. 
Since we couldn’t find an alternative explanation of AVN 
in this patient and presence of clinical and laboratory fea-
tures of chronic inflammatory disorder justified consid-
ering all above manifestations were related to an evolving 
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case of SLE, which she ultimately met the diagnostic 
criteria.
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